Preliminary Results of the First-in-Human Study of Nexi-001, a Multi-Antigen Specific CD8+ T Cell Product, in Acute Myeloid Leukemia (AML) Patients with Relapsed Disease after Allogeneic Hematopoietic Cell Transplantation (Allo-HSCT) Demonstrate Early Signs of Safety, Tolerability and Robust Immune Responses

Saved in:
Bibliographic Details
Published in:Transplantation and cellular therapy 2021-03, Vol.27 (3), p.S213-S214
Main Authors: Al Malki, Monzr M., Vasu, Sumithira, Modi, Dipenkumar, Perales, Miguel, Nelson, Megan, Bui, Donna, Edavana, Vineetha, Kim, Sojung, Suarez, Lauren, Oelke, Mathias, Myint, Han, Varela, Juan C.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-6367
2666-6367
DOI:10.1016/S2666-6367(21)00262-1